Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

16 Dec 2020

Abstract excerpt

The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical characteristics with other acute viral infections. We studied the whole-blood transcriptomic host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using RNAseq from 24 healthy controls and 62 prospectively enrolled patients with COVID-19. We then compared these data to non-COVID-19 viral infections, curated from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Respiratory viral infections research
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33437935
DOI: 10.1016/j.isci.2020.101947

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infectionsPMID 33437935Read ↗

Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral InfectionsSemantic proximity Read ↗

Transcriptomic dysregulations associated with SARS-CoV-2 infection in human nasopharyngeal and peripheral blood mononuclear cellsSemantic proximity Read ↗

Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in bloodSemantic proximity Read ↗

Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 diseaseSemantic proximity Read ↗

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsSemantic proximity Read ↗

Analysis of Transcriptomics Data from COVID-19 Patients: Pilot ResearchSemantic proximity Read ↗

Characterisation of the blood RNA host response underpinning severity in COVID-19 patientsSemantic proximity Read ↗

Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysisSemantic proximity Read ↗

Transcriptomics secondary analysis of severe human infection with SARS-CoV-2 identifies gene expression changes and predicts three transcriptional biomarkers in leukocytesSemantic proximity Read ↗

Comprehensive Transcriptomic Analysis of COVID-19 Blood, Lung, and AirwaySemantic proximity Read ↗

Dysregulated transcriptional responses to SARS-CoV-2 in the peripherySemantic proximity Read ↗

Dysregulated transcriptional responses to SARS-CoV-2 in the periphery support novel diagnostic approachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.